Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer.

Autor: Agaoglu NB; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Genetics, Division of Cancer Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey.; Frankfurter Institut für Klinische Krebsforschung IKF, Frankfurt, Germany., Ng OH; Department of Medical Biology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.; Department of Medical Genetics, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.; Acibadem University Rare Diseases and Orphan Drugs Application and Research Center, Istanbul, Turkey., Zemheri IE; Department of Pathology, Umraniye Training and Research Hospital, Istanbul, Turkey., Unal B; Department of Medical Genetics, Division of Cancer Genetics, Umraniye Training and Research Hospital, Istanbul, Turkey., Gerenli N; Department of Pediatric Gastroenterology, Umraniye Training and Research Hospital, Istanbul, Turkey., Tosun I; Department of Pathology, Umraniye Training and Research Hospital, Istanbul, Turkey., Yazıcı H; Oncology Institute, Istanbul University, Istanbul, Turkey.; Department of Medical Genetics and Biology, Medical School, Istanbul Health and Technology University, Istanbul, Turkey., Ozbek U; Department of Medical Genetics, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.; Izmir Biomedicine and Genome Center (IBG), Izmir, Turkey., Kamihara J; Department of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publikováno v: American journal of medical genetics. Part A [Am J Med Genet A] 2024 Oct 11, pp. e63897. Date of Electronic Publication: 2024 Oct 11.

Delivery of BikDD proapoptotic gene in Peptide-18-targeted Poly(2-oxazoline)-DOPE nanoliposomes for breast cancer models.

Autor: Bolat ZB; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Ataşehir, İstanbul, Turkiye.; Department of Molecular Biology and Genetics, Hamidiye Institute of Health Sciences, University of Health Sciences-Türkiye, İstanbul, Turkiye.; Experimental Medicine Research and Application Center, University of Health Sciences İstanbul, Turkiye., Nezir AE; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Ataşehir, İstanbul, Turkiye., Saka OM; Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkiye., Zemheri IE; Department of Pathology, Umraniye Training and Research Hospital, İstanbul, Turkiye., Gülyüz S; Materials Institute, Marmara Research Center, TÜBİTAK, Gebze, Turkiye.; Department of Chemistry, Faculty of Science and Letters, İstanbul Technical University, İstanbul, Turkiye., Özköse UU; Materials Institute, Marmara Research Center, TÜBİTAK, Gebze, Turkiye.; Department of Chemistry, Faculty of Science and Letters, İstanbul Technical University, İstanbul, Turkiye.; Department of Chemistry, Faculty of Science and Letters, Piri Reis University, İstanbul, Turkiye., Yilmaz Ö; Materials Institute, Marmara Research Center, TÜBİTAK, Gebze, Turkiye., Bozkir A; Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkiye., Telci D; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Ataşehir, İstanbul, Turkiye., Şahin F; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Ataşehir, İstanbul, Turkiye.

Publikováno v: Turkish journal of biology = Turk biyoloji dergisi [Turk J Biol] 2024 Sep 05; Vol. 48 (5), pp. 299-307. Date of Electronic Publication: 2024 Sep 05 (Print Publication: 2024).

PEtOx-DOPE nanoliposomes functionalized with peptide 563 in targeted BikDDA delivery to prostate cancer.

Autor: Nezir AE; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, İstanbul, Turkiye., Bolat ZB; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, İstanbul, Turkiye.; Department of Molecular Biology and Genetics, Hamidiye Institute of Health Sciences, University of Health Sciences, İstanbul, Turkiye.; Experimental Medicine Research and Application Center, University of Health Sciences, İstanbul, Turkiye., Saka OM; Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkiye., Zemheri IE; Department of Pathology, Ümraniye Training and Research Hospital, University of Health Sciences, İstanbul, Turkiye., Gülyüz S; Materials Technologies, Marmara Research Center, TÜBİTAK, Kocaeli, Turkiye.; Department of Chemistry, Faculty of Science and Letters, İstanbul Technical University, İstanbul, Turkiye., Özköse UU; Materials Technologies, Marmara Research Center, TÜBİTAK, Kocaeli, Turkiye.; Department of Chemistry, Faculty of Science and Letters, İstanbul Technical University, İstanbul, Turkiye.; Department of Chemistry, Faculty of Science and Letters, Piri Reis University, İstanbul, Turkiye., Yilmaz Ö; Materials Technologies, Marmara Research Center, TÜBİTAK, Kocaeli, Turkiye., Bozkir A; Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Ankara, Turkiye., Şahin F; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, İstanbul, Turkiye., Telci D; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, İstanbul, Turkiye.

Publikováno v: Turkish journal of biology = Turk biyoloji dergisi [Turk J Biol] 2024 May 23; Vol. 48 (3), pp. 174-181. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).

Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.

Autor: Karakus IS; School of Medicine, Marmara University, Istanbul, Turkey., Catak MC; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey., Frohne A; Anna Children's Cancer Research Institute, Vienna, Austria., Bayram Catak F; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey., Yorgun Altunbas M; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey., Babayeva R; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey., Bal SK; Anna Children's Cancer Research Institute, Vienna, Austria., Eltan SB; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey., Yalcin Gungoren E; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey., Esen F; Department of Ophthalmology, School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey., Zemheri IE; Department of Pathology, Umraniye Education and Research Hospital, University of Health Sciences, Istanbul, Turkey., Karakoc-Aydiner E; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey., Ozen A; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey., Caki-Kilic S; Division of Pediatric Hematology, Umraniye Education and Research Hospital, University of Health Sciences, Istanbul, Turkey., Kraakman MJ; Anna Children's Cancer Research Institute, Vienna, Austria., Boztug K; Anna Children's Cancer Research Institute, Vienna, Austria.; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Anna Children's Hospital, Vienna, Austria., Baris S; Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik/Istanbul, Turkey. safabaris@hotmail.com.; Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey. safabaris@hotmail.com.; The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey. safabaris@hotmail.com.

Publikováno v: Journal of clinical immunology [J Clin Immunol] 2024 Apr 05; Vol. 44 (4), pp. 94. Date of Electronic Publication: 2024 Apr 05.

Actinomycosis of parotid gland after maxillary molar extraction, case report and review of literature.

Autor: Güvendir İ; Pathology Department, Health Sciences University, Umraniye Training and Research Hospital, Elmalikent Mahallesi, Adem Yavuz Bulvarı, No: 1, Posta Code: 34766, Umraniye/Istanbul/Turkey., Karabulut MH; Pathology Department, Health Sciences University, Umraniye Training and Research Hospital, Elmalikent Mahallesi, Adem Yavuz Bulvarı, No: 1, Posta Code: 34766, Umraniye/Istanbul/Turkey., Zemheri IE; Pathology Department, Health Sciences University, Umraniye Training and Research Hospital, Elmalikent Mahallesi, Adem Yavuz Bulvarı, No: 1, Posta Code: 34766, Umraniye/Istanbul/Turkey.

Publikováno v: Journal of oral and maxillofacial pathology : JOMFP [J Oral Maxillofac Pathol] 2023 Feb; Vol. 27 (Suppl 1), pp. S45-S51. Date of Electronic Publication: 2023 Feb 04.